News for Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics (PLRX) presented key clinical and preclinical data on its drug bexotegrast at the American Thoracic Society 2025 International Conferen

**media[633480]**

Pliant Therapeutics (PLRX) has been actively advancing its research, with significant efforts put into concluding the global BEACON-IPF trial. The company plans

Pliant Therapeutics (PLRX) has been actively concluding the global BEACON-IPF trial, targeting the announcement of key data in the upcoming quarter. Efforts hav

Activities supporting the close out of BEACON-IPF continue; topline data expected in the second quarter of 2025 Recently announced strategic realignment of wor

Pliant Therapeutics (PLRX) has unveiled a strategic overhaul of its operations, which includes a significant workforce reduction and other cost-saving measures,

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (”œPliant” or the ”œ

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (”œPliant” or the ”œ

**media[588419]**

Pliant Therapeutics' stock plummeted, but Kevin Tang’s stake raises takeover hopes. Find out why PLRX stock’s cash reserves present a compelling investment.

On March 3, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction by acquiring 5,859,044 shares of Pliant Therapeutics Inc (PLRX)

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across multiple tumor types PLN-101095 was gener

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. ( PLRX) today announced that its Board of Directors has unanimously

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Significant Transaction by FMR LLC (Trades, Portfolio) On February 28, 2025, FMR LLC (Trades, Portfolio) executed a notable transaction involving Pliant Therape

PR NewswireNEW YORK, March 4, 2025 NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeut

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant T